Illumina to cut $100M in costs to cope with China ban
The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.
Diagnostic Kit Maker Illumina To Cut $100 Million In Costs, Lowers 2025 Profit Outlook Amid China Trade Restrictions
Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...
Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban
Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China ...
Yahoo Finance1d
Illumina, Inc. (ILMN)
Here are the biggest headlines of the day in the latest Market Minute. Illumina (ILMN ... banned imports of the biotech’s gene sequencing machines as part of a broader retaliatory response ...
How Trump's new order on Canadian tariffs is impacting stock market
US stocks opened mostly down as worries over the tariffs and the economy linger. Companies say consumer demand's slowing and ...
The Business Times2d
Walmart faces heat from Beijing after demand for price cuts
NEW YORK] Chinese authorities summoned Walmart executives on Tuesday (Mar 11) over reports it asked suppliers to bear rising ...
AOL4d
Stock market opens mostly down amid recession fears, tariffs, signs of consumer slowdown
Illumina lowered its 2025 financial guidance and plans to reduce spending because China barred sales of its devices. Shares of the maker of genetic-sequencing machines added almost 3%. Bitcoin ...
Breast Cancer Diagnostics Market Set For 6.9% CAGR Growth, Projected To Hit USD 12.45 Billion By 2035
Rise in prevalence of cancer and the necessary attention in early diagnosis and treatment to boost market demand, States Fact.MRRockville, MD, ...